Navamedic ASA: Significant growth across the business Published: 11.08.2023 Navamedic ASA: Invitation to 2023 2nd quarter presentation Published: 07.08.2023 Navamedic ASA: Annual Report for 2022 Published: 28.04.2023 Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Published: 22.04.2023 Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Published: 29.03.2023 Navamedic ASA: Q4 2022 financial results Published: 16.02.2023 FirstPrevious23456NextLast
Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Published: 22.04.2023
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Published: 29.03.2023